Monographie - Epirubicin hydrochloride

Последно актуализиране :
19/11/2024

Epirubicin hydrochloride

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Anthracine	Малайзия
Axirubicine	Германия
Bendaepi	Германия
Binarin	Мексико
Bioepycina	Полша
Crisabon	Аржентина
Cuatroepi	Аржентина
Ecclepia	Румъния
Elebicin	Мексико
Ellence	Съединени Американски щати / САЩ
Epi Cell	Германия
Epidoxo	Аржентина, Венецуела, Чили
Epifil	Еквадор
Epilem	Колумбия, Мексико
Epimedac	Германия
Epirubicin	Австралия, Австрия, Белгия, Великобритания, Дания, Исландия, нова Зеландия, Саудитска Арабия, Турция, Унгария, Швейцария, Швеция
Epirubicina	Аржентина, Еквадор, Испания, Колумбия, Мексико, Румъния
Epirubicine	Белгия, Франция, Швейцария
Farmarubicin	Турция
Farmorubicin	Австрия, Бразилия, Гърция, Дания, Норвегия, Саудитска Арабия, Финландия, Швейцария, Швеция
Farmorubicin CSV	Южноафриканска република / ЮАР
Farmorubicin PFS	Полша, Словения, Хърватия
Farmorubicin RD	Бразилия, Полша, Русия, Швейцария
Farmorubicin RTU	Холандия
Farmorubicina	Бразилия, Испания, Италия, Португалия
Farmorubicine	Белгия, Франция
Pharmorubicin	Великобритания

Библиография : Epirubicin hydrochloride

	Вид	Публикация
148	Списание	Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525	Списание	De Vroe C, De Muynck C, Remon JP, Samsom M. A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. Int J Pharm 1990 ; 65: 49-56.
683	Списание	Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 1990 ; 43: 265-272.
686	Списание	Wood MJ, Irwin WJ, Scott DK. Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. J Clin Pharm Ther 1990 ; 15: 279-289.
887	Списание	Pujol M, Munoz M, Prat J, Giona V, De Bolos J. Stability study of epirubicin in NaCl 0.9% injection. Ann Pharmacotherapy 1997 ; 31: 992-995.
1237	Списание	Keusters L, Stolk LML, Umans R, Van Asten P. Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation. Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265	Списание	Wood MJ, Irwin WJ, Scott DK. Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. J Clin Pharm Ther 1990 ; 15: 291-300.
1317	Списание	Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J 1987 ; 238: 476-478.
1662	Списание	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1823	Списание	Sewell GJ, Rigby-Jones AE, Priston MJ. Stability of intravesical epirubicin infusion: a sequential temperature study. J Clin Pharm Ther 2003 ; 28: 349-353.
1897	Списание	Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. EJHP 2001 ; 7, 3: 108-115.
1955	Списание	Trissel LA, Zhang Y. Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Ann Pharmacotherapy 2005 ; 39: 280-283.
2168	Списание	Ozdemir FA, Anilanmert B, Pekin M. Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257	Лаборатория	Stability of epirubicin "Ebewe" infusion solutions. Ebewe Pharma 2007
3473	Списание	Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Int J Pharm 2015 ; 495, 2: 956-962.
3474	Лаборатория	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3632	Лаборатория	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics Hospira 2017
3670	Списание	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3708	Плакат	Sarakbi I, Thiesen J, Krämer I. Compatibility of epirubicin-loaded DC Beads with different contrast media. ECOP 2 Krakow 2014
3918	Списание	Sarakbi I, Krämer I. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. J Oncol Pharm Practice 2016 ; 22: 749-756.
4352	Списание	Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. J Clin Pharm Ther 2019 ; 44: 875-882.

Mentions Légales